“We are pleased that Algernon NeuroScience has selected Netcapital Securities as its broker-dealer to provide critical compliance and operational support for this offering,” said Martin Kay, CEO at ...

Algernon Pharmaceuticals (AGNPF) announced that its wholly owned subsidiary Algernon NeuroScience, has appointed Netcapital Securities for its ...

Disease-modifying therapies (DMTs) may help lower the risk of children's bone fractures in spinal muscular atrophy (SMA), a ...

Ocrevus treatment was linked to increases in myelin and reductions in iron in MS patients with paramagnetic rim lesions, per ...